Rouse Co.The Columbia-based company reported yesterday...

BY THE NUMBERS

May 16, 1992

Rouse Co.

The Columbia-based company reported yesterday first-quarter earnings before depreciation and deferred taxes of $10.9 million, up slightly from $10.7 million in the same quarter last year.

"Our first-quarter results represent a good start to the year. Retail centers performed very well, and Columbia land sales were ahead of our expectations," said the company's chief executive, Mathias J. DeVito.

A conservative approach to management through the real estate downturn has served the company well, said David L. Tripp, who heads investor relations for Rouse.

Depreciation and amortization cost the company nearly $16 million during the quarter while the tax benefit and sale of assets provided $2.5 million in additional income.

Last year's net income figure includes a gain of $13.5 million related to an accounting change.

Three months ended 3/31/92

.. .. .. Revenue .. .. .. Net .. .. .. .. .. Share

'92 .. 38,459,000 .. .. (2,530,000) .. .. (.05)

'91 .. 135,087,000 .. .. 9,939,000 .. .. .. .21

% change .. .. +2.5 .. .. .. -- .. .. .. .. .. --

Noise Cancellation

Technologies

This developer of electronic equipment to control noise and vibration posted a $1.36 million loss during the quarter that ended March 31, in contrast to a profit of $50,000 in the same period last year.

Chairman John J. McCloy II said the loss was not unexpected. He said 1992 is expected to be a year of transition for the company from a research and development concern to a product-oriented business.

Revenues totaled $948,000, down from $2.2 million in the 1991 period, during which the company benefited from a $1 million licensing fee.

Noise Cancellation, which is based in Stamford, Conn., has a research and development facility in Linthicum.

Three months ended 3/31/92

.. .. .. Revenue .. .. .. Net .. .. .. .. Share

'92 .. 948,000 .. .. ..(1,355,000).. ..(0.02)

'91 .. 2,162,000 .. .. .. 50,000 .. .. 0.00*

% change -56.2 .. .. .. .. ..-- .. .. .. .. --

* Per share figure is less than 1 cent.

Penta Systems International

This Baltimore-based software company, which sells computerized text processing and corporate publishing systems, reported yesterday a $35,000 loss for the quarter that ended March 31, contrasting with a $207,000 loss in the first quarter a year ago.

Fred Ayres, the company's president, attributed most of the improvement to the closing during the third quarter last year of Penta's unprofitable subsidiary in France. The company now serves that market through a distributorship.

L Mr. Ayres said U.S. sales have also showed some improvement.

Three months ended 3/31/92

.. .. .. .. Revenue .. .. .. .. Net .. .. .. .. .. .. Share

'91 .. .. 1,154,000 .. .. .. (35,000) .. .. .. ..(0.01)

'90 .. .. 1,794,000 .. .. .. (207,000) .. .. .. ..(0.05)

% change .. -35.7 .. .. .. .. .. .. -- .. .. .. .. .. .. --

Interstate General Corp. L.P.

This real estate partnership based in St. Charles reported yesterday that it made substantial progress during the first quarter in reducing the size of its losses.

The publicly traded partnership had a loss of $118,000 in the first quarter, about one-fourth the $446,000 it lost in the same quarter last year.

"We have begun to to see a turnaround in home sales," James J. Wilson, the partnership's chairman, said. "Home settlements were up 33 percent from last year's first quarter, and our backlog of home sales improved by 27 percent."

He said the company plans to convert assets to cash to relieve liquidity problems.

Three months ended 3/31/92

.. .. .. Revenue .. .. .. .. Net .. .. .. .. .. .. Unit

'91 .. 11,154,000 .. .. (118,000) .. .. .. .. .. (0.01)

'90 .. 11,022,000 .. .. (446,000) .. .. .. .. .. (0.04)

% change .. +01.2 .. .. .. .. -- .. .. .. .. .. .. .. --

Cryomedical Sciences Inc.

This Rockville medical company reported a loss of $1.2 million for its third fiscal quarter, which ended March 31, compared to a loss of $518,000 for the same period in 1992.

The larger loss came as the biomedical company geared up to sell its first product, a medical device that will be used to freeze cancer tumors, enabling doctors to minimize surgery when treating patients with prostate and liver cancer. Company executives said they have 10 orders for the devices, which sell for $150,000 each.

Currently, the company's revenue comes from interest income. The company had $13.1 million in cash and other short-term investments as of April 30.

Three months ended 3/31/92

.. .. Revenue .. .. .. .. .. Net .. .. .. .. .. .. .. Share

'92.. 40,463 .. .. .. ..(1,249,471).. .. .. .. .. .. (0.07)

'91.. ..29,384 .. .. .. ..(518,031) .. .. .. .. .. .. (0.04)

% change +37.7 .. .. .. .. .. -- .. .. .. .. .. .. .. ..--

Nine months ended 3/31/92

.. .. .. Revenue .. .. .. .. Net .. .. .. .. .. Share

'92.. .. 171,475 .. .. .. (3,159,047).. .. .. ..(0.18)

'91.. .. 139,082.. .. .. .(2,003,433).. .. .. .. (0.14)

% change .. +23.3.. .. .. .. -- .. .. .. .. .. .. ..--

Baltimore Sun Articles
|
|
|
Please note the green-lined linked article text has been applied commercially without any involvement from our newsroom editors, reporters or any other editorial staff.